Victor Van de Wiele

Victor Van de Wiele

Partnerships & GTM

Victor holds law degrees from Queen Mary, University of London and Georgetown University, with a background spanning patent law and pharmaceuticals. He has authored 20 peer-reviewed publications in scientific journals including Nature Biotechnology and JAMA, and co-founded ClaimWise, which was acquired by Solve Intelligence. Over the past four years, he has worked closely with patent attorneys across the EU and US on integrating AI into their prosecution and litigation workflows.

Related articles

LAC 2026: What Generic and Biosimilar IP Teams Think About AI

Generic and biosimilar IP teams are already using AI for prosecution history and FTO work. The live debate is not about adoption, but internal framing of quality and coverage extension without reducing headcount. The teams furthest along chose the former.

Key takeaways

  • Generic and biosimilar IP teams use AI primarily for prosecution history summaries, invalidity analysis and FTO claim charting.
  • Viewing AI as a quality and coverage extension drives durable internal adoption.
  • General-purpose AI cannot reliably interpret claim scope from prosecution history; patent-specific tools are required.
Legal News